XIAOMI(HK:01810) 36氪·2025-09-20 02:49Group 1 - Xiaomi Automotive Technology Co., Ltd. has announced a recall of 116,887 units of the SU7 standard version electric vehicles due to safety concerns, with production dates ranging from February 6, 2024, to August 30, 2025 [4] - The recall will be executed in compliance with the "Defective Automobile Products Recall Management Regulations" and will involve free software upgrades via over-the-air (OTA) technology to eliminate safety hazards [4][5] Group 2 - The court has sentenced Zhai Xinxin to 12 years in prison for extortion, with a fine of 100,000 RMB and compensation for economic losses amounting to 70,000 RMB [5][6] - The case highlights the legal consequences of extortion and the importance of evidence in establishing the nature of the crime [6] Group 3 - Chasing Technology has announced plans to launch its first smartphone, Dreame Space, which has already secured over 100 million RMB in pre-orders in overseas markets [7] - The company aims to position itself in the high-end market, targeting a price point above 5,000 RMB, competing with established brands like Huawei and Xiaomi [7] Group 4 - JD Beauty has reported double-digit growth in the first half of 2025, leading the high-end market segment, with over a hundred domestic and international beauty brands participating in its first "Beauty Award" ceremony [9][10] - The awards will be held annually to provide insights for the beauty industry based on sales and reputation metrics [10] Group 5 - FedEx reported better-than-expected earnings for the first quarter, with an adjusted EPS of $3.83, surpassing analyst expectations of $3.59 [20] - The company has projected an adjusted EPS for the full year between $17.20 and $19.00, indicating strong financial performance [20] Group 6 - GE Healthcare is exploring options for its China division, which could be valued at several billion dollars, although no final decisions have been made yet [15] - The company emphasizes its commitment to providing high-quality medical services in China, which is one of the largest healthcare markets globally [15]